RecruitingPhase 1Phase 2NCT03965234

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Phase I/ II Study of Pulmonary Suffusion to Control Minimal Residual Disease in Resectable or Ablatable Sarcoma or Colorectal Pulmonary Metastases


Sponsor

Roswell Park Cancer Institute

Enrollment

99 participants

Start Date

Jul 16, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This phase I/II trial studies the side effects of pulmonary suffusion in controlling minimal residual disease in patients with sarcoma or colorectal carcinoma that has spread to the lungs. Pulmonary suffusion is a minimally invasive delivery of chemotherapeutic agents like cisplatin to lung tissues. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Pulmonary suffusion may also be useful in avoiding later use of drugs by vein that demonstrate no effect on tumors when delivered locally.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a specialized lung treatment called pulmonary suffusion — a technique that delivers cancer-fighting drugs directly into the lungs in high concentrations via a catheter system — for patients with cancer that has spread to the lungs from soft tissue sarcoma, bone sarcoma, or colorectal cancer. The goal is to control remaining cancer cells after surgery or other treatments. **You may be eligible if...** - You have lung metastases from soft tissue sarcoma, osteosarcoma, or colorectal cancer - You are in adequate physical condition (ECOG performance status 2 or less) - Your blood counts and organ function are adequate - You are willing to undergo the suffusion procedure **You may NOT be eligible if...** - Your cancer has spread to other organs beyond the lungs in an uncontrolled way - You have severe breathing problems or lung disease that makes this procedure unsafe - You have had recent major surgery - You are pregnant or breastfeeding - You have very poor blood counts Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCisplatin

Given via infusion

PROCEDUREIsolated Chemotherapeutic Lung Perfusion

Undergo pulmonary suffusion

PROCEDUREMetastasectomy

Undergo metastasectomy


Locations(1)

Roswell Park Cancer Institute

Buffalo, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03965234


Related Trials